Global Health Limited has informed the Exchange about change in Management
MEDANTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Global Health Limited (Medanta) reported strong FY2026 results with consolidated revenue of ₹44,103 million (up 19.4% YoY) and PAT of ₹5,541 million (up 15.1% YoY). The Board approved audited financial results with unmodified audit opinion from Walker Chandiok & Co LLP. A final dividend of ₹0.50 per share (25% on ₹2 face value) has been recommended, subject to shareholder approval. Two senior appointments were made: Mr. Kedar Ashok Apte as Chief Marketing & Growth Officer and Mr. Jagdeep Singh as General Counsel, both effective May 14, 2026. Ms. Richa Singh has tendered resignation as SMP effective May 20, 2026. The company also announced expansion plans including a 400-bed hospital in Varanasi and acquisition of a 79-bed oncology hospital in Indore.
The resignation of Ms. Richa Singh represents a management change at senior level which investors should monitor, though the strong financial performance and expansion announcements are positive signals for the healthcare operator.